Overview
Lobbying Costs
25,000€ - 49,999€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
1.75 Fte (3)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Hellenic Association of Pharmaceutical Companies (SFEE)
EU Transparency Register
684432824847-17 First registered on 01 Dec 2016
Goals / Remit
The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive and extrovert sectors of the national economy. It encompasses more than 95% of the pharmaceutical industry operating in Greece. Its 61 member companies – 17 Greek and 44 international– are constantly investing in the development of effective medicines and treatments to safeguard the right of all citizens to health and better quality of life.
SFEE was established in 1982 and for more than 30 years now has championed the common interests of patients, pharmaceutical companies and their workforce. Since 1983, SFEE has been a member of EFPIA (European Federation of Pharmaceutical Industries and Associations), which is the voice of the pharmaceutical industry at the European Union level. As of 2021, SFEE is also a member of IFPMA (International Federation of Pharmaceutical Manufacturers and Associations).Main EU files targeted
- European Pharmaceutical Strategy
- EU Industrial Strategy
- Review of the OMP and Paediatrics Regulations
- European HTA
- European Presidencies
- Patients Access to healthcare
- Cross-country collaborations
- European SemesterAddress
Head Office
289 Kifissias av. and 3 Agriniou str
Halandri 15232
GREECEEU Office
289 Kifissias av. and 3 Agriniou str
Halandri 15232
GREECEWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 75% 1 50% 2 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 13 May 2022
Name Start date End Date POLYXENI PAPADONIKOLAKI 23 Sep 2024 23 Sep 2025 Complementary Information
These activities are under the Public Affairs Department, which is the main responsible, with the participation of the General Manager and the President of the Association.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
SFEE is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
http://efpia.eu/
SFEE is a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
https://www.ifpma.org/
SFEE is a member of the Hellenic Federation of Enerprises (SEV)
http://www.sev.org.grMember organisations
AbbVie Pharmaceuticals S.A
ADELCO S.A.
ALERGAN
AMGEN HELLAS Pharmaceuticals EPE
ANABIOSIS P.C.
ANGELINI Pharma Hellas S.A.
ARRIANI Pharmaceuticals S.A.
ASTELLAS Pharmaceuticals S.A.
ASTRAZENECA S.A
BAUSCH HEALTH
BAXTER HELLAS Ltd
BAYER HELLAS A.G.
ΒΕΝΝΕΤΤ Pharmaceuticals Α.Ε.
VIATRIS
VIAN S.A.
VIANEX S.A.
BOEHRINGER INGELHEIM Εllas Α.Ε.
BRISTOL-MYERS SQUIBB S.A.
CHIESI Hellas S.A.
CSL BEHRING Ελλάς Μ.Ε.Π.Ε.
GENESIS Pharma S.A.
DEMO S.A.
ELPEN PHARMACEUTICAL Co. INC.
FARAN
FERRING
FRESENIUS KABI
GALENICA S.A.
GE HEALTHCARE S.A.
GILEAD Sciences Hellas Ltd
GLAXOSMITHKLINE S.A.
HELP S.A.
ITF Hellas A.E.
INNOVIS
IPSEN ΕPΕ
JANSSEN – CILAG PHARMACEUTICAL S.A.C.I.
LAVIPHARM S.A.
LEO Pharmaceuticals Hellas S.A.
LUNDBECK HELLAS S.A.
MENARINI Hellas S.A.
MERCK S.A.
MSD (MERCK SHARP & DOHME)
NOVARTIS HELLAS A.E.
NOVO NORDISK HELLAS LTD
ORION Pharma Hellas MEPE
PIERRE FABRE Farmaka S.A.
PFIZER HELLAS S.A.
LILLY
PHARMAZAC
PHARMEX
RECORDATI
ROCHE
SANOFI-AVENTIS S.A.
SERVIER Hellas L.T.D.
SOBI
SPECIFAR S.A.
TAKEDA HELLAS S.A.
UCB A.E.
WIN MEDICA Pharmaceutical SA -
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
25,000€ - 49,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
Name symeon tsomokos sa Closed year Costs
25,000€ - 49,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
SFEE is having official meetings with European Parliament Members and other stakeholders regarding the National and European Agenda on healthcare and pharmacueticals.
Communication activities
-Publication of studies and reports in collaboration with external parties
-Public events with stakeholders (policy debates, roundtable discussions, policy conferences)Other activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 08 Apr 2022 Location Delphi Subject Pharma strategy in EU and Greece Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
-
Date 01 Oct 2020 Location Virtual event Subject EU Health Policies Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 29 Nov 2016 Location Berlaymont Subject exchange of vies on Pharmaceutical products distribution in refugee camps in Greece Cabinet Cabinet of Commissioner Christos Stylianides Portfolio Humanitarian Aid & Crisis Management Attending - Christos Stylianides (Commissioner)